A 50 year-old woman with iron deficiency anemia, renal failure and colitis: case report and brief review of literature
Abstract
Keywords
Full Text:
PDFReferences
Sellier-Leclerc AL, Fremeaux-Bacchi V, Macher MA, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007; 18:2392-2400.
Kavanagh D, Raman S, Sheerin NS. Management of hemolytic uremic syndrome. F1000Prime Rep 2014; 6:119.
Mohlin FC, Nilsson SC, Levart TK, et al. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients. Mol Immunol 2015; 65(2):367-376.
Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol 2008; 23(11):1951-1956.
Fakhouri F, Frémeaux-Bacchi V, Loirat C. Atypical hemolytic uremic syndrome: From the rediscovery of complement to targeted therapy. Eur J Int Med 2013; 24(6):492-495.
Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial a HUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5(10):1844-1859.
Sullivan M, Erlic Z, Hoffmann MM, et al. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Ann Hum Genet 2010; 74(1):17-26.
Thorpe CM. Shiga toxin-producing Escherichia coli infection. Clin Infect Dis 2004; 38(9):1298-1303.
Walker WA. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 4th Edition. Hamilton, Ont.: BC Decker, 2004.
DOI: http://dx.doi.org/10.22551/2015.05.0201.10030
Copyright (c) 2015 Archive of Clinical Cases
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975